CRP and atherosclerosis: Importantly, mCRP is increasingly recognized not just as a byproduct but as an active mediator of local inflammation in various pathological conditions, including atherosclerosis, neurodegenerative diseases, and autoimmune disorders, underscoring the need to distinguish between CRP isoforms in both research and clinical settings [17,18].